000 01520 a2200421 4500
005 20250515125253.0
264 0 _c20080829
008 200808s 0 0 eng d
022 _a1097-6825
024 7 _a10.1016/j.jaci.2008.06.010
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSimon, Dagmar
245 0 0 _aAlefacept (lymphocyte function-associated molecule 3/IgG fusion protein) treatment for atopic eczema.
_h[electronic resource]
260 _bThe Journal of allergy and clinical immunology
_cAug 2008
300 _a423-4 p.
_bdigital
500 _aPublication Type: Clinical Trial; Letter; Research Support, Non-U.S. Gov't
650 0 4 _aAdrenal Cortex Hormones
_xadministration & dosage
650 0 4 _aAdult
650 0 4 _aAlefacept
650 0 4 _aCytokines
_xbiosynthesis
650 0 4 _aDermatitis, Atopic
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPilot Projects
650 0 4 _aRNA, Messenger
_xmetabolism
650 0 4 _aRecombinant Fusion Proteins
_xadministration & dosage
650 0 4 _aSeverity of Illness Index
650 0 4 _aT-Lymphocyte Subsets
_ximmunology
700 1 _aWittwer, Jennifer
700 1 _aKostylina, Ganna
700 1 _aBuettiker, Urs
700 1 _aSimon, Hans-Uwe
700 1 _aYawalkar, Nikhil
773 0 _tThe Journal of allergy and clinical immunology
_gvol. 122
_gno. 2
_gp. 423-4
856 4 0 _uhttps://doi.org/10.1016/j.jaci.2008.06.010
_zAvailable from publisher's website
999 _c18085004
_d18085004